CTTC

The Center for Technology Transfer and Commercialization has honored five faculty members as 2024 Master Innovators for their groundbreaking research and transformative innovations. These pioneers, recognized for achievements spanning patents, startups and impactful technologies, exemplify Vanderbilt's dedication to translating academic excellence into societal advancements. Read More

Vanderbilt University has awarded a new cycle of Innovation Catalyst Fund grants to pioneering faculty projects that advance health care technology, AI tools for research impact and wearable devices. These grants support translational research and drive real-world solutions across disciplines, underscoring Vanderbilt's commitment to fostering innovation and societal impact. Read More

Infectious diseases pose a significant global health challenge, accounting for a substantial proportion of deaths worldwide, according to recent data from the World Health Organization. Vanderbilt’s Life Science Showcase: Advancing Innovation in Infectious Diseases held on July 18 emphasized the vital importance of advancing research and innovation to combat these persistent threats. Read More

Vanderbilt has announced the February 2024 Innovation Catalyst Fund awardees, propelling groundbreaking research into practical applications. Read More

Donna Ingles, director of operations for the Vanderbilt Center for Technology Transfer and Commercialization, has been named to the 2024 Young American Leaders Program at Harvard Business School by the Global Action Platform. She was one of 10 local leaders chosen for the program, which aims to create a biomedical economic development strategy for the region using cluster models devised by Harvard economist Michael Porter. Read More

Vanderbilt University’s Center for Technology Transfer and Commercialization has launched the Concept Submission Form, a simple online tool aimed at streamlining the process for faculty to submit innovative ideas with potential for patenting and commercialization. Read More

The Vanderbilt Innovation Catalyst Fund honors eight projects in its inaugural pre-seed funding round, showcasing the university’s commitment to transforming research into real-world solutions. Read More

In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials.     Read More

School of Medicine Basic Sciences researchers at the forefront of Charcot-Marie-Tooth disease research and therapeutic development join CTTC leadership at CMT Research Foundation global research convention. The CMTRF has invested in further research at Vanderbilt to address the primary genetic cause of disease in patients with CMT disease type 1A. Read More

Vanderbilt's Center for Technology Transfer and Commercialization named Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher 2023 Master Innovators. The yearly recognition program acknowledges Vanderbilt’s top innovators and entrepreneurs for their contributions to the creation, development, and commercialization of intellectual property. Read More

Laurie Cutting, a renowned scholar and expert in cognitive neuroscience, has been appointed associate provost in the Office of the Vice Provost for Research and Innovation, where she will aim to foster academic excellence, innovation and interdisciplinary collaboration. Read More

Vanderbilt tech transfer sets records: $86.7M in licensing revenue in FY22 ranks sixth-highest nationally, and $96M in licensing revenue in FY23 is largest in university history. Revamped processes in the Center for Technology Transfer and Commercialization makes licensing and launching new ventures faster and easier than ever before. Read More

The inaugural Life Science Showcase highlighted recent successes and opportunities to spur growth in state-of-the-art research across small molecules, vaccines, antibodies, medical devices in development and more. The July 19 event brought together leaders in academia and industry on Vanderbilt University’s campus. Read More

Chris Rowe, executive director for industry collaborations within Vanderbilt's Office of the Vice Provost for Research and Innovation and professor of the practice of engineering management, has been chosen for the 2023 Young American Leaders Program at Harvard Business School. He’ll join a task force focused on enhancing Nashville's biomedical sector, using cluster models to drive economic growth and innovation. Read More

Seed and Series A funding to three startups—HeroWear, IDBiologics and Virtuoso—rooted in research conducted at Vanderbilt University and Vanderbilt University Medical Center underscore a university-wide commitment to enhanced support for Vanderbilt’s most innovative faculty, students and alumni. Read More

Vanderbilt’s Center for Technology Transfer and Commercialization streamlines innovation’s path from campus to the marketplace. Read More

Vanderbilt anesthesiologist Susan Eagle will be the inaugural speaker in a new seminar series, “From Concept to Commercialization: Translational and Entrepreneurial Journeys.” Eagle will speak on Tuesday, March 21, at 2 p.m. in Light Hall, Room 208. Read More

Vanderbilt University leaders hosted visitors from the health care investment firm Deerfield Management on Feb. 23 for a series of events celebrating the ongoing collaboration between Vanderbilt and Deerfield to rapidly advance new therapeutics from the research bench to patients. Read More

Current biomedical sciences Ph.D. students, postdocs affiliated with the School of Medicine Basic Sciences, and Vanderbilt University Medical Center postdocs interested in transitioning from research to entrepreneurship are invited to apply for the next ASPIRE to Innovate Postdoctoral Fellowship through the Office of Biomedical Research Education and Training. Read More

Research in the Weaver lab leads to discoveries that help secure partnership with Ancora Innovation LLC.  “Vanderbilt is at the forefront of genetic research. By understanding the genetic causes of disease opens exciting new opportunities to develop drugs to treat them more effectively,” said Matt Nelson, vice president, genetics and genomics, 3DC at Deerfield Management.  Read More